SGLT2 inhibitors: cardiorenal metabolic drugs for the ages is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK NIH HHS
Grant: R01 DK129676
NIDDK NIH HHS
Grant: R01 DK097554
NIDDK NIH HHS
Grant: R01 DK107680
NIDDK NIH HHS
Grant: U01 DK098246
NIDDK NIH HHS
Grant: R01 DK024092
National Institutes of Health
Grant: 3R01DK024092-18S1
REGULATION OF HEPATIC AND PERIPHERAL GLUCOSE METABOLISM
National Institutes of Health
Grant: 1R01DK129676-01A1
Targeting hepatic mitochondrial function in humans with NAFLD using insulin sensitizers
National Institutes of Health
Grant: 3R01DK107680-06A1S1
Ketones, Muscle Metabolism, and SGLT2 Inhibitors
FWCI
2.10
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords